Description
Roots Analysis recently published a report on the global Non-Viral Drug Delivery Systems Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.
Market Size and Forecast
Current Market Size:$11.3 Billion
Future Market Size: $20.4 Billion
CAGR: 6.8%
Market Overview
This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.
This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.
Market Scope and Segmentation
- Forecast Period: Till 2035
- Market Size 2026: $11.3 Billion
- Market Size 2035: $20.4 Billion
- CAGR till 2035: 6.8%
- Type of Molecule Delivered
• Biologics
• Small Molecules
- Type of Biologic Delivered
• RNA
• DNA
• Proteins / Peptides
• Antibodies
- Type of Vehicle Used
• Nanoparticles
• Extracellular Vesicles
• Polymers
• Oligonucleotides
• Cell Penetrating Peptides
- Target Therapeutic Area
• Oncological Disorders
• Infectious Diseases
• Cardiovascular Disorders
• Genetic Disorders
• Hepatic Disorders
• Metabolic Disorders
• Neurological Disorders
• Pulmonary Disorders
• Rare Disorders
• Other Disorders
- Type of Payment Employed
• Upfront Payments
• Milestone Payments
- Key Geographical Regions
• North America (US and Canada)
• Europe (UK, Germany, Belgium, Ireland, Denmark and Rest of Europe)
• Asia-Pacific (South Korea, Australia and China)
- Companies Profiled
• Arcturus Therapeutics
• Bio-Path Holdings
• CureVac
• Entos Pharmaceuticals
• etherna
• Matinas Biopharma
• MDimune
• PCI Biotech
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary)
• Technology Landscape
• Technology Competitiveness Analysis
• Partnerships and Collaborations
• Patent Analysis
• Opportunity Assessment Framework
• Market Forecast and Future Opportunity Analysis
Read More: https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html
By Region
North America (, US and Canada, ), Europe (, UK, Germany, Belgium, Ireland, Denmark and Rest of Europe, ), Asia-Pacific (, South Korea, Australia and China, )
This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities.
Technological and Strategic Insights
The Roots Analysis report includes a detailed assessment of:
- Technological advancements and R&D activity
- Innovations in formulation and delivery methods
- Marketing and distribution strategies
- Pricing models and cost structures
- Manufacturing capacities and supply chain trends
These insights are presented neutrally, supported by empirical evidence and primary research validation.
Key Market Players
Profiles of prominent companies include:
Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune, PCI Biotech
Each profile highlights:
- Product portfolio and focus areas
- Operational footprint and regional presence
- Financial and strategic performance
- Recent developments (e.g., partnerships, market entries, acquisitions)
Regional Insights
Each region is analyzed based on:
- Historical and current market size
- Revenue performance
- Contribution to global share
- Strategic developments and regional trends
Comparative insights across regions enable targeted market entry and expansion strategies.
Report Structure
- Part 01: Market Overview
- Part 02: Market Size, by Regions
- Part 03: Market Revenue, by Countries
- Part 04: Market Competition, by Key Players
- Part 05: Company Profiles